Turning science into business: Merging AI and RNA
Drug Discovery World
FEBRUARY 27, 2023
DDW’s Diana Spencer speaks to Raphael Townshend PhD, Founder and CEO of Atomic AI, about the company’s successes so far, plans for the future and the unique approach of combining RNA structural biology and AI models. These two factors together made it evident that a business was the best solution versus an academic research project.
Let's personalize your content